ELMS STEVE bought MRKR
November 17, 2025 · Form 4 insider transaction
ELMS STEVE bought 84,411 shares of Marker Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
84,411
Price
$0.00
Total value
N/A
InsiderELMS STEVE
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateNovember 17, 2025
Filing dateNovember 19, 2025
Shares owned after84,411
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents options granted under the Company's 2020 Omnibus Stock Ownership Plan for the remaining options due as service as a director for the year 2024. 30,000 shares were previously granted on February 12, 2025. The options vest on the anniversary of the grant date. The option exercise price is the closing price on the date of the grant, November 17, 2025.